Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease.

Author: Kappel, Ben A. MD, PhD; Lehrke, Michael MD; Schutt, Katharina MD; Artati, Anna PhD; Adamski, Jerzy PhD; Lebherz, Corinna MD; Marx, Nikolaus MD

Page: 969-972

http://ift.tt/2eDBOBu